◀ Back to CSF2

CSF2 — ITGAX

Text-mined interactions from Literome

Kushner et al., Blood 1992 (Neoplasms) : Granulocyte-macrophage colony stimulating factor ( GM-CSF ) significantly increased the expression of CD11b, CD11c , and CD18 on normal PMN, decreased the expression of Fc receptors ( FcR ), and enhanced ADCC by normal but not by LAD PMN
Ganesh et al., Int Immunol 2009 (Thyroiditis, Autoimmune) : GM-CSF induced CD11c+CD8a -- dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis
Zhu et al., PloS one 2012 : GM-CSF increased the 5.3 Kb CD11c proximal promoter activity in monocyte derived DCs and CD8 ( + ) lymphoid derived DCs, but not in B220 ( + ) plasmacytoid DCs
Socinski et al., Blood 1988 : To assess the possible in vivo significance of these observations we studied the effect of GM-CSF on CD11b, CD11a ( LFA-1 ), and CD11c ( gp 150, 95 ) expression on granulocytes from nine adult patients with sarcoma who were receiving GM-CSF as part of a phase I trial
Rubio et al., Blood 1995 (Lymphoma, Large B-Cell, Diffuse) : Granulocyte-macrophage colony stimulating factor , phorbol ester, and sodium butyrate induce the CD11c integrin gene promoter activity during myeloid cell differentiation
Rivier et al., Int Arch Allergy Immunol 1994 : GM-CSF induced the expression of CD11c and CD23 and the release of sCD23